Keros Therapeutics Inc (KROS) stock news · rev $243.9M
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
This KROS news page leads with what Keros Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for KROS yet. We will not pad this page with generic market recap.
Latest reported KROS revenue for 2025-12-31 was $243.9M. Net income was $87.0M. KROS currently screens at market cap $208.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KROS stock page; for the tape open the quote page.
KROS stock news FAQ
What are KROS's latest revenue and net income?
Latest cached Keros Therapeutics Inc (KROS) revenue for Dec 31, 2025 was $243.9M. Net income was $87.0M. Statements: https://lician.com/financials/kros
What is KROS's market cap?
Keros Therapeutics Inc (KROS) market cap is $208.8M on the latest cached fundamentals snapshot.
What kind of company is KROS?
Keros Therapeutics Inc (KROS) is a biotechnology company listed on US.
Where is KROS stock news listed?
Cached stock news for Keros Therapeutics Inc (KROS) is listed at https://lician.com/news/kros. Filings: https://lician.com/sec/kros
Not investment advice.